OptimizeRx Corp filed 3 current reports with the SEC under Item 5.02, which covers directors and officers leaving or being appointed, the latest on 2026-08-12. Between them they name 2 people, with 1 appointment and 1 departure. Each change below is quoted from the filing and linked to it.
Every change, newest first
Departing: Edward Stelmakh, effective 2026-12-31
Pursuant to the plan, Edward Stelmakh will step down as Chief Financial & Strategy Officer effective December 31, 2026.
Appointed: Heather Favazza, Chief Accounting Officer, effective 2027-01-01
Mr. Andrew D'Silva will become Chief Financial Officer and Ms. Heather Favazza will become Chief Accounting Officer, each effective January 1, 2027.
Reported
Accordingly, effective as of the Separation Date, Ms. Greco will no longer serve as the Company's Chief Commercial Officer.
Reported
The appointment of Ms. Varghese Presti as an independent director is in furtherance of the Company's ongoing process to refresh and expand its Board.
Find people with the same kind of experience as the Chief Accounting Officer at OptimizeRx Corp, with the record behind each one.
Find candidates like Chief Accounting Officer at OptimizeRx CorpNew leaders review vendors and budgets in their first months. Get an alert the next time OptimizeRx Corp is in the news or changes leadership.
Get an alert when OptimizeRx Corp changes leadershipTools for this story
Each opens in a new tab, filled in for OptimizeRx Corp. With no account yet, you sign up free and land on the result.
Where this comes from
A public company must file a current report on Form 8-K with the SEC within four business days when a director leaves or is elected, or when its chief executive, chief financial, chief accounting or chief operating officer, or another named executive, departs or is appointed. That disclosure goes under Item 5.02 of the report.
Every change on this page is taken from one of those filings and quoted in the company's own words, with a link to the filing, so it can be checked at the source. Where a filing names the person, the role and the date a change takes effect, they are shown beside the quote. Where it does not, the quote stands on its own. A filing states what changed; it rarely states why, and neither does this page.